JPMorgan Chase to Expand in Alabama With 24 New Branches-February 2024-www.financetom.com

JPMorgan Chase to Expand in Alabama With 24 New Branches

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

JPMorgan Chase to Expand in Alabama With 24 New Branches

Feb 5, 2025 9:57 AM

12:39 PM EST, 02/05/2025 (MT Newswires) -- JPMorgan Chase ( JPM ) said Wednesday it intends to expand operations in Alabama by opening 24 new branches, bringing the total to 35 by 2030.

An additional 170 bankers will be hired to support the expansion, according to the company.

Price: 269.03, Change: +1.09, Percent Change: +0.41

Previous page： DuPont secures 10-year US import ban on China's Dawnsens in Tyvek case Next page： Rapport Reports Promising Epilepsy Study Outcomes, Plans Phase 3 Trials Next Year

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

DuPont secures 10-year US import ban on China's Dawnsens in Tyvek case

Sep 8, 2025

Sept 8 (Reuters) - DuPont ( DD ) said on Monday China's Dawnsens New-Materials will not sell or import products tied to the chemical company's Tyvek brand in the U.S. for 10 years, as part of a trade secrets dispute resolution. The International Trade Commission approved Dawnsens', also known as Dangs, voluntary agreement to the consent order. The ban, effective...

Rapport Reports Promising Epilepsy Study Outcomes, Plans Phase 3 Trials Next Year

Sep 8, 2025

Rapport Therapeutics, Inc. ( RAPP ) stock traded higher on Monday, with a session volume of 3.20 million compared to the average volume of 179.3 thousand, according to data from Benzinga Pro. On Monday, the company revealed data from the Phase 2a trial of RAP-219 (RAP-219-FOS-201) in patients with drug-resistant focal onset seizures. The study met its primary endpoint, demonstrating...

ImmunityBio Says Anktiva Therapy Prolonged Overall Survival in Phase 2 Non-Small Cell Lung Cancer Study

Sep 8, 2025

09:27 AM EDT, 09/08/2025 (MT Newswires) -- ImmunityBio ( IBRX ) said Monday that results from its phase 2 study showed Anktiva therapy reverses lymphopenia and prolongs overall survival in patients with advanced non-small cell lung cancer. Lymphopenia is an adverse effect associated with chemotherapy, radiotherapy, and immunotherapy, and it lowers overall survival rates in various types of cancer, the...

Bath & Body Works to Hire Over 30,000 Seasonal Workers Ahead of Holidays

Sep 8, 2025

09:29 AM EDT, 09/08/2025 (MT Newswires) -- Bath & Body Works ( BBWI ) said Monday it plans to hire 30,000 seasonal associates across the US, Canada, and Puerto Rico to meet the expected surge in demand during the holiday season. Roles include part-time seasonal associates to support nearly 1,900 stores and over 2,000 full-time merchandise processors, handlers, outbound loaders...